Polar Capital LLP - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 182 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Polar Capital LLP ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$25,830,000
+86.5%
600,425
+113.0%
0.28%
+133.9%
Q3 2018$13,852,000
+1614.4%
281,824
+1027.3%
0.12%
+807.7%
Q4 2016$808,000
-30.8%
25,000
-26.7%
0.01%
-35.0%
Q3 2016$1,167,000
-28.2%
34,100
-29.2%
0.02%
-35.5%
Q2 2016$1,626,000
+17.9%
48,196
+85.1%
0.03%
+19.2%
Q1 2016$1,379,000
-14.5%
26,034
+24.0%
0.03%
-10.3%
Q4 2015$1,612,000
+163.4%
20,989
+41.0%
0.03%
+141.7%
Q3 2015$612,000
-75.2%
14,890
-57.4%
0.01%
-75.0%
Q2 2015$2,470,000
+288.4%
34,920
+388.2%
0.05%
+300.0%
Q1 2015$636,000
+41.0%
7,153
+40.6%
0.01%
+33.3%
Q4 2014$451,000
-96.7%
5,087
-97.4%
0.01%
-97.1%
Q1 2014$13,794,000
-21.7%
197,091
-35.7%
0.32%
-24.8%
Q4 2013$17,621,000
+1.7%
306,544
-14.9%
0.42%
-9.5%
Q3 2013$17,332,000
+57.8%
360,419
-4.8%
0.46%
+21.2%
Q2 2013$10,983,000378,7180.38%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Tamarack Advisers, LP 360,000$21,845,0006.19%
Gagnon Advisors, LLC 213,217$12,938,0004.92%
GAGNON SECURITIES LLC 499,333$30,300,0004.30%
Spyglass Capital Management LLC 2,117,673$128,500,0002.86%
NEUMEIER POMA INVESTMENT COUNSEL LLC 646,530$39,231,0002.30%
Paulson & Co. 1,273,161$77,255,0001.85%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 212,112$12,871,0001.44%
Tygh Capital Management, Inc. 152,332$9,244,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,147,000$69,600,0001.24%
Rock Springs Capital Management LP 1,025,000$62,197,0001.23%
View complete list of PACIRA PHARMACEUTICALS INC shareholders